Letter from the editor
págs. 171-172
Idebenone for Leber's hereditary optic neuropathy.
N Gueven
págs. 173-182
PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemia.
David M. Paton
págs. 183-192
The impact of SPRINT on the future treatment of hypertension: a mini review.
Steven G. Chrysant
págs. 193-198
Duchenne muscular dystrophy drugs face tough path to approval.
L. Hodgkinson, Lisa Ann Sorbera, Ann I. Graul
págs. 199-202
Pharma Pricing & Market Access Europe 2016 – Health Network Communications' Tenth Annual Conference (February 23-25, 2016 – London, UK).
A.P. Souza
págs. 203-206
Evidence 2016 – A Health Network Communications Conference (February 24-25, 2016 – London, UK).
Alexandra Kibble
págs. 207-210
New product intros
págs. 211-213
© 2001-2026 Fundación Dialnet · Todos los derechos reservados
Coordinado por: